Doherty Catherine T. sold DGX

February 13, 2026 · Form 4 insider transaction

Doherty Catherine T. sold 10,573 shares of Quest Diagnostics Incorporated at $205.21 per share, a transaction worth $2.17M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
10,573
Price
$205.21
Total value
$2.17M
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after83,660
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.; This transaction was executed in multiple trades at prices ranging from $204.745 to $205.740. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR
Doherty Catherine T. sold DGX: February 13, 2026 | Insider Trading Screener